Objective: To develop a highly sensitive LC-MS/MS (liquid chromatography-mass spectrometry/mass spectrometry) method applied to the detection and quantitation of UDCA (ursodeoxycholic acid) related substances such as CA (cholic acid), DCA (deoxycholic acid), CDCA (chenodeoxycholic acid) and LCA (lithocholic acid) in raw material and pharmaceutical formulation. Methods: The method was validated for specificity, linearity, accuracy, precision, robustness. A triple quadrupole mass detector was employed, equipped with an ESI (electrospray ionization) source operated in the negative ion mode. The chromatographic system consisted of a Symmetry C18 column (150 mm × 4.6 mm, id; particle size 5 µm) and methanol-acetonitrile-ammonium acetate (pH 7.6; 10 mM) (40:40:20, v/v/v) as the mobile phase. The chromatographic conditions were 25 uL injection volume, flow rate of 0.4 mL/min and column temperature set at 35 °C. Key findings: The method requires a minimum sample amount and presents very low LOD (limits of detection) for CA (0.29 ng/mL), DCA (0.59 ng/mL), CDCA (0.13 ng/mL) and LCA (0.44 ng/mL) in comparison to LC methods coupled to different detectors like UV (ultraviolet), fluorescence and refractive index. Conclusions: The developed and validated LC-MS/MS method for the determination of UDCA and related substances in raw material and in a suspension was advantageous since it required a minimum sample amount. In turn, it could be used as a stability indicating method.
Introduction
 UDCA (Ursodeoxycholic acid), (3α, 7β-dihydroxy-5β-cholan-24-oic acid), also known as ursodiol, is a naturally occurring BA (bile acid). BAs are steroid compounds, hydroxyl derivatives of 5β-cholan-24 oic acid [1] . Primary BA, CA (are cholic acid) and CDCA (chenodeoxycholic acid); secondary BA such as DCA (deoxycholic acid) and LCA hepatotoxicity, with LCA being the most toxic, all of them can be found as potential related substances [5] along with CA. The USP(United States Pharmacopeia) UDCA official monograph proposes an HPLC (high performance liquid chromatography) method coupled to a differential refractive index detector for its analysis in raw material and a TLC (thin layer chromatography) method for the evaluation of CDCA and LCA as its related substances [6] . Moreover, the EP (European Pharmacopoeia) UDCA monograph presents a TLC method for the analysis of related substances; CA, CDCA, LCA and other related BA like DCA [7] . Due to the low absorptivity of BA, high concentration is needed for UV (ultraviolet) detection and also for TLC. Moreover, several analytical methods applied to the evaluation of the UDCA related substances have been reported. Most of them describe HPLC coupled to various detectors: UV [5] , electrochemical [8] , prederivatization fluorescence [5, 9] , evaporative light scattering [10] and refractive index [5, 11] . Another method such as CE (capillary electrophoresis) has also been applied [12] [13] [14] . In this sense, in a previous work, we developed CE-UV methods applied to determination of BA in pharmaceutical formulations as well as the evaluation of UDCA related substances [12, 14] . Although CE methods were suitable for the analysis of BA in pharmaceutical formulations and raw material, they require high sample concentrations and CE is not common laboratory equipment.
LC-MS/MS Method Applied to the Detection and Quantification of Ursodeoxycholic Acid Related Substances in Raw Material and Pharmaceutical Formulation
On the other hand, HPLC tandem mass spectrometry [15] is the methodology of choice for the analysis of BA in biological samples, especially HPLC-MS (mass spectrometry) and HPLC-MS/MS which provide high sensitivity and specificity [16] .
The aim of this work was to develop and validate for the first time a highly sensitive HPLC tandem MS/MS method for the evaluation of UDCA related substances in raw material and pharmaceutical formulation as a stability indicating method. To our knowledge, there is no report in literature on the use of an LC-MS/MS method to the analysis of UDCA related substances, in raw material and pharmaceutical formulation. 
Materials and Methods

Chemicals and Reagents
Equipment and Chromatographic Conditions
The LC-MS/MS analyses were performed on an Ultimate 3000 System HPLC system (Thermo Fisher Scientific, Inc, San Jose, CA, USA) coupled to TSQ Quantum AcessMax mass spectrometer (Thermo Fisher Scientific, Inc, San Jose, CA, USA). The LC was equipped with an autosampler, quaternary pump, mobile phase online degasser and a thermostatted column compartment. The chromatographic separation was carried out isocratically using a Symmetry C18 column (150 mm × 4.6 mm, id; particle size 5 µm) supplied by Waters (Milford, Massachusetts, USA). The mobile phase consisted of methanol-acetonitrile-10 mM ammonium acetate (40:40:20, v/v/v). The flow rate was set at 0.6 mL/min. The column temperature was set at 40°C. The injection volume was 20 µL and the running time was 10 minutes.
The TSQ Quantum Access Max triple quadrupole mass spectrometer was equipped with an ESI (electrospray ionization) source and was operated in the negative ion mode. The optimal values for MS parameters were: 4,500 V for spray voltage, 60 and 45 for sheath and auxiliary gas pressure, respectively, 280 °C for capillary temperature and 53 eV for collision energy. Data acquisition was performed using Xcalibur 2.1 software (Thermo Fisher Scientific, Inc, San Jose, CA, USA).
Preparation of Stock, Standard and Sample Solution
Preparation of Stock and Standard Solutions
Totally, 400 mg of UDCA was accurately weighed and transferred to a 100 mL volumetric flask and dissolved in methanol to give a stock solution concentration of 4 mg/mL. Stock solutions of CA, DCA, CDCA, all of 4 µg/mL and 1 µg/mL LCA, were prepared by appropriate dilution in methanol/acetonitrile (50:50). Standard solution containing UDCA (40 µg/mL), CA (0.2 µg/mL), DCA (0.1 µg/mL), CDCA (0.4 µg/mL) and LCA (0.02 µg/mL) was prepared by appropriate dilution in mobile phase.
2.3.2 Preparation of Sample Solution 2.3.2.1 UDCA raw material. For the analysis of CA, DCA, CDCA and LCA related substances, approximately 400 mg of UDCA raw material was accurately weighed in a 100 mL volumetric flask and dissolved in methanol. A 1/10 dilution was prepared in methanol/acetonitrile (50:50). This was further diluted with mobile phase to a final concentration of 40 µg/mL.
Pharmaceutical suspension.
The UDCA suspension was shaken vigorously by hand immediately before use. A total of 16 g was transferred to a 100 mL volumetric flask and filled up with methanol, sonicated for 5 min and centrifuged at 15,000 rpm for 10 min to separate the insoluble components. A 1/10 dilution of the supernatant was prepared in methanol/acetonitrile (50:50). This was further diluted with mobile phase to a final concentration of 40 µg/mL.
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Method Validation
The developed method was validated according to ICH (International Council for Harmonisation) guidelines [17] . Parameters such as specificity, linearity, LOD (limits of detection) and LOQ (limits of quantification), precision, accuracy and robustness were tested.
Specificity
A blank of excipients of the pharmaceutical suspension was prepared to test specificity.
2.4.2 Linearity, LOD and LOQ Linearity was assayed at five concentration levels for each related compound within the range of 50-625 ng/mL for CA, 25-425 ng/mL for DCA, 50-800 ng/mL for CDCA and 10-115 ng/mL for LCA, where each concentration was injected by triplicate. Regression coefficients were obtained by plotting the average peak area versus concentration, using the least squares method. LOD and LOQ were determined in six replicates, as 3 and 10 times S/N, respectively. RSD (relative standard deviation) for peak area was calculated.
Precision
Precision was evaluated for intra-day (n = 6) and inter-day (n = 18) for CA (207 ng/mL), DCA (119 ng/ml), CDCA (422 ng/mL) and LCA (21 ng/mL) under the conditions described in preparation of stock and standard solutions. Precision was determined as RSD for peak area and retention time.
2.4.4 Accuracy Accuracy was calculated as recovery. Samples were prepared with all excipients present in the suspension, the active pharmaceutical ingredient and subsequently supplemented with CA, DCA, CDCA and LCA at three different concentration levels (related to limit values for each related substance): 80%; 100% and 120%, three replicates of each level. The 100% level is related to the limit value of each related substance, that is: not more than 0.5% for CA, not more than 0.25% DCA, not more than 1% and not more than 0.05% LCA. The RSD for each related substances area was calculated.
Robustness
Robustness was evaluated for flow rate (+/-0.05 mL/min), column temperature (+/-2°C) and injection volume (+/-1 µL). The effect on chromatographic parameters such as retention factor, tailing factor, RSD for CA, DCA, CDCA and LCA standard solution at 207 ng/mL, 119 ng/mL, 422 ng/mL and 21 ng/mL, respectively, were evaluated.
Related Substances Analysis
The developed method was applied to the analysis of related substances in raw material and pharmaceutical suspension. Sample solutions were prepared according to preparation of sample solutions. Quantification of related substances was performed under the conditions described in equipment and chromatographic conditions.
Results and Discussion
Method Development
The aim of this work was to develop an HPLC-MS/MS method for the detection and quantification of UDCA and related substances in raw material and suspension.
The USP UDCA monograph describes CDCA and LCA as related substances, where each related substance limit should not be more than 1.5% w/w and 0.05% w/w, respectively. At the same time, the European Pharmacopoeia refers to CA, DCA, CDCA and LCA as related substances, where each related substance limit should not be more than 0.5% w/w, 0.25% w/w, 1.0% w/w and 0.1% w/w, respectively
The chromatographic conditions were optimized to achieve good resolution, symmetric peak shapes and a 
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Buffer concentration was an important factor to optimize. Higher concentrations of ammonium acetate could improve resolution, but with lower sensitivity.
Therefore, 10 mM ammonium acetate was a good choice in terms of resolution and sensitivity.
The mass detector was equipped with an ESI (electrospray ionization) source and was operated in the negative ion mode as BAs have an acidic group in their chemical structure. The operational conditions were optimized to obtain an efficient ionization (equipment and chromatographic conditions).
A mix standard solution of UDCA, CA, DCA, CDCA and LCA was presented in Fig. 2 .
The parent-ion and product-ion pairs of UDCA, CA, DCA, CDCA and LCA were analyzed. The unequivocal identification of CA, DCA, CDCA and LCA was achieved using the product-ion (qualifier ion) and retention times. However, given that UDCA, DCA and CDCA have the same fragmentation pattern, the quantitation of CA, DCA, CDCA and LCA was made using the respective molecular ion (which is considered as the quantifier ion). Nevertheless, SRM (selected reaction monitoring) mode of the molecular ions with a collision energy of 5 eV, was preferred to SIM (selected ion monitoring) mode in order to avoid adducts formation and improve sensitivity (Fig. 3) .
Comparison of Methods
Several LC methods coupled to different detectors applied to the evaluation of UDCA related substances have been reported. However, detection limits are higher than mass detector, for example 0.08 µg/mL and 400 µg/mL for fluorescence and UV detection, respectively. Mass spectrometry provides higher sensitivity with lower detection limits. The refractive index detector is used in the USP method for UDCA raw material. In this sense, Peepliwal et al. have developed an LC method coupled to a refractive index detector using methanol instead of acetonitrile (the latter used in the USP method). However, up to 0.14% of UDCA related substances in raw material are detected with this method. Moreover, other methodologies as CE or TLC also present low sensitivity.
The use of the mass detector provides an excellent sensitivity with a minimum sample amount compared to other methods for UDCA related substances.
Method Validation
Specificity
This was evaluated by comparing the chromatograms of the blank of excipients of the pharmaceutical suspension with the standard solution. No peaks were observed in the chromatogram of the blank of excipients.
3.3.1 Linearity, LOD and LOQ Linearity was evaluated in the range of 0.12-1.55%, 0.06-1.06%, 0.12-2.00% and 0.03-0.30% (% w/w respect to UDCA) for CA, DCA, CDCA and LCA, respectively. The results showed good correlation coefficients, higher than 0.9901 (Table 1) . LODs for CA, DCA, CDCA and LCA were 0.0007%, 0.0020%, 0.0003% and 0.0011% (%w/w respect to UDCA), respectively. LOQs for CA, DCA, CDCA and LCA were 0.002%, 0.005%, 0.001% and 0.004% (%w/w respect to UDCA), respectively. RSD values for LOD and LOQ were lower than 2% ( Table 1) . The low LOD and LOQ values show the high sensitivity of the method. 
Precision and Accuracy
Precision and accuracy results are shown in Table 1 . The method provides good precision with RSD values lower than 0.3% for retention time; as for peak areas, RSD values were lower than 2.5%. Recovery values in raw material and suspension ranged from 95.0-106.3% to 90.6-108.9%, respectively. The results obtained for precision and accuracy studies were in good agreement with international requirements.
3.3.3 Robustness All parameters were evaluated in terms of CA, DCA, CDCA and LCA retention factor, tailing factor and RSD for replicates of standard solutions (n = 6). In all cases, RSD values lower than 3% were obtained; this demonstrates that the proposed method is suitable for the determination of UDCA related substances.
Analysis of Related Substances in Raw Material and pharmaceutical Suspension
Once the validation was completed, CA, DCA, CDCA and LCA quantification in raw material and suspension was evaluated. CA and DCA have not been found in raw material and pharmaceutical formulations. The results are showed in Table 2 .
Conclusions
An LC-MS/MS method for the quantification of CA, DCA, CDCA and LCA as related substances in UDCA raw material and pharmaceutical suspension was developed and validated for the first time. This method is simple, fast, precise, exact and robust and specially, highly specific and sensitive allowing the use of a minimal sample amount. In conclusion, this method can be used for UDCA routine laboratory analysis and to monitor the stability and quality control in UDCA pharmaceutical formulations.
